Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on LHC Group (NASDAQ:LHCG) on Thursday, setting a price target of $250, which is approximately 21.56% above the present share price of $205.66.
Wiederhorn expects LHC Group to post earnings per share (EPS) of $0.47 for the first quarter of 2021.
The current consensus among 6 TipRanks analysts is for a Strong Buy rating of shares in LHC Group, with an average price target of $254.67.
The analysts price targets range from a high of $260 to a low of $245.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $530.68 million and a net profit of $19.54 million. The company's market cap is $6.5 billion.
According to TipRanks.com, Oppenheimer analyst Michael Wiederhorn is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 23.0% and a 74.09% success rate.
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including skilled nursing, private duty nursing, physical, occupational and speech therapy, medically-oriented social services and hospice care. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel by operating an institutional pharmacy, which focuses on providing a full array of services to long term acute care hospitals. The Healthcare Innovations segment reports on developmental activities outside its other business segments, which provides primary medical care for patients with chronic and acute illnesses who have difficulty traveling to a doctor's office. LHC Group was founded by Keith G. Myers in September 1994 and is headquartered in Lafayette, LA.